Clinical and metabolic effects of yasmin plus metformin and dianette plus metformin in women with polycystic ovary syndrome and metabolic disorders: a randomized controlled trial.
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2017
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; Ethinylestradiol/cyproterone (Primary) ; Metformin
- Indications Insulin resistance; Polycystic ovary syndrome
- Focus Pharmacodynamics; Therapeutic Use
- 21 Dec 2012 Status changed from recruiting to completed.
- 12 Oct 2012 Results presented at the 20th FIGO World Congress of Gynecology and Obstetrics.
- 21 May 2012 Planned end date changed from 1 Mar 2012 to 1 Sep 2011 as reported by Chinese Clinical Trial Register record.